Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: A phase II study conducted by the Hellenic Cooperative Oncology GroupC. Nicolaides, Nikolaos Pavlidis, Meletios Α. Dimopoulos et al.|Annals of Oncology|2000Cited by 50
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, Dimitrios Bafaloukos, Amanda Psyrri et al.|Cancer Immunology Immunotherapy|2021Cited by 39
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, G. Koumakis, Georgia-Angeliki Koliou et al.|ESMO Open|2020Cited by 38
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)George Pentheroudakis, George Fountzilas, Vassiliki Kotoula et al.|BMC Cancer|2014Cited by 35